Health
Asian nations scale back AstraZeneca rollout amid safety woes – The Japan Times
The moves may delay protection for the region amid concerns that the shot could trigger a rare and potentially deadly blood clotting condition.
Countries across the Asia Pacific are demurring on AstraZeneca PLCs COVID-19 vaccine, or restricting its use, in moves that may delay protection for the region amid concerns that the shot could trigger a rare and potentially deadly blood clotting condition.
After guiding against the vaccines use in people under 50 and saying that it didnt expect shipments from Europe to arrive on time, Australias government abandoned a pledge that everyone in the country would receive a first dose by October.
In…
-
General20 hours agoAustralia Kangaroos lose Xavier Coates and Zac Lomax ahead of rugby league Ashes in England
-
Business24 hours agoDoes Macquarie rate Karoon Energy shares a buy, hold or sell?
-
General6 hours agoPolice investigating after body found on road in Newborough, Gippsland
-
General18 hours agoRobin Williams’s daughter begs fans to stop making AI content of her father